Anti-eIF4A3 antibody
4
(9 Reviews)
|
(34 Publications)
Rabbit Polyclonal eIF4A3 antibody. Suitable for IHC-P, IP, WB, ICC/IF and reacts with Human, Rat samples. Cited in 34 publications.
View Alternative Names
DDX48, KIAA0111, EIF4A3, Eukaryotic initiation factor 4A-III, eIF-4A-III, eIF4A-III, ATP-dependent RNA helicase DDX48, ATP-dependent RNA helicase eIF4A-3, DEAD box protein 48, Eukaryotic initiation factor 4A-like NUK-34, Eukaryotic translation initiation factor 4A isoform 3, Nuclear matrix protein 265, NMP 265, hNMP 265
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-eIF4A3 antibody (AB32485)
ICC/IF image of ab32485 stained human HeLa cells. The cells were PFA fixed (10 min), permabilised in TBS-T (20 min) and incubated with the antibody (ab32485, 5μg/ml) for 1h at room temperature. 1%BSA / 10% normal serum / 0.3M glycine was used to quench autofluorescence and block non-specific protein-protein interactions. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red). DAPI was used to stain the cell nuclei (blue).
- IP
Unknown
Immunoprecipitation - Anti-eIF4A3 antibody (AB32485)
eIF4A3 was immunoprecipitated using 0.5mg Hela whole cell extract, 5μg of Rabbit polyclonal to eIF4A3 and 50μl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, Hela whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40μl SDS loading buffer and incubated for 10min at 70°C; 10μl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab32485.
Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697).
Band : 47kDa; eIF4A3
All lanes:
Immunoprecipitation - Anti-eIF4A3 antibody (ab32485)
Predicted band size: 47 kDa
true
Exposure time: 20min
- WB
Project
Western blot - Anti-eIF4A3 antibody (AB32485)
All lanes:
Western blot - Anti-eIF4A3 antibody (ab32485) at 1 µg/mL
All lanes:
HeLa (Human epithelial carcinoma cell line) Nuclear Lysate at 20 µg
Secondary
All lanes:
IR Dye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/15000 dilution
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
- WB
Project
Western blot - Anti-eIF4A3 antibody (AB32485)
All lanes:
Western blot - Anti-eIF4A3 antibody (ab32485) at 1 µg/mL
Lane 1:
MEF1 (Mouse embryonic fibroblast cell line) Whole Cell Lysate at 10 µg
Lane 2:
PC12 (Rat adrenal pheochromocytoma cell line) Whole Cell Lysate at 10 µg
Secondary
All lanes:
IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution
Predicted band size: 47 kDa
Observed band size: 100 kDa,46 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF4A3 engages in nonsense-mediated mRNA decay and plays a role in mRNA splicing. It is an important component of the exon junction complex (EJC) which includes other proteins like MAGOH and Y14. This complex ensures proper mRNA surveillance by marking transcripts that need to be subject to degradation if errors are found.
Pathways
EIF4A3 interacts with cellular processes such as mRNA surveillance and splicing. It integrates within the nonsense-mediated decay (NMD) pathway and the spliceosome-associated pathways. eIF4A3's activity closely relates to proteins like UPF1 and RNPS1 which coordinate the removal of defective mRNA and support mRNA splicing.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (34)
Recent publications for all applications. Explore the full list and refine your search
World journal of diabetes 16:105173 PubMed40548267
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:19979 PubMed40481141
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:2434 PubMed40069174
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 28:e70098 PubMed39307884
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 43:114666 PubMed39182224
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational vision science & technology 13:12 PubMed38587436
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 29:155 PubMed37940881
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 38:e23530 PubMed37822284
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 9:161 PubMed37179359
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Kaohsiung journal of medical sciences 39:478-488 PubMed37098796
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com